We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Urinary Enzyme Levels Correlate with Prediabetic Plasma Glucose

By LabMedica International staff writers
Posted on 22 Jan 2013
Urinary N-acetyl-β-D-glucosaminidase (NAG) excretion is increased in patients with impaired glucose tolerance (IGT).

During the oral glucose tolerance test (OGTT) the plasma glucose, urine glucose, and insulin levels correlate strongly with urinary N-acetyl-β-d-glucosaminidase (NAG) levels in prediabetic subjects.

Scientists at the Nippon Medical School (Tokyo, Japan) performed OGTTs on 33 men and 47 women, aged 18 to79 years, who were not yet diagnosed with diabetes mellitus (DM), and in whom HbA1c levels were equal to or greater than 6.8%. More...
The study was carried out from December 2005 through August 2010.

Urinary NAG levels were measured spectrophotometrically with sodio- metacresolsulfonphthaleinyl- N-acetyl-β-D-glucosaminide as a substrate (NAG assay kit, Shionogi & Co., Osaka, Japan). Urinary glucose levels and serum creatinine (Cr) levels were measured with enzymatic assays. The serum levels of cystatin C were measured with the N Latex Cystatin C kit (Siemens Healthcare Diagnostics, Inc., Marburg, Germany) and the fully automated particle-enhanced nephelometric immunoassay.

Forty-two subjects had normal glucose tolerance (NGT), 31 had impaired glucose tolerance (IGT), and seven had DM. NAG levels were significantly higher in subjects with DM and in subjects with IGT than in subjects with NGT. Urinary NAG in the DM group was 8.53 ± 4.96 U/g UCr, which was elevated compared to the NGT group, which ranged from 5.40 ± 3.82 U/g UCr. The IGT group's range was 6.60 ± 2.88 U/g UCr, which was also significantly higher than the nondiabetic group. The NAG level was positively correlated with plasma glucose levels at 120 minutes of the OGTT and was associated with the glycemic status of prediabetic patients.

The authors concluded that that the urinary excretion of NAG with other urinary enzymes in the prediabetic state is an appropriate biomarker for screening for prediabetic renal dysfunction. Their results suggest that postprandial hyperglycemia is an independent factor that causes renal tubular damage in prediabetes patients. The study was published on November 9, 2012, in the Journal of Clinical Laboratory Analysis.

Related Links:

Nippon Medical School
Shionogi & Co.
Siemens Healthcare Diagnostics



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.